Tirofiban for the Prevention of Neurological Deterioration in Acute Ischemic Stroke

NCT04491695 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

420

Enrollment

OTHER

Sponsor class

Conditions

Acute Stroke

Interventions

DRUG: Tirofiban Hydrochloride
DRUG: Oral antiplatelet

Sponsor

Capital Medical University